PREDOMINANCE OF SERUM ANTIBODIES TO SYNTHETIC PEPTIDE STEMMING FROM HPV-18 OPEN READING FRAME E2 IN CERVICAL ADENOCARCINOMA

被引:16
作者
LEHTINEN, M
LEMINEN, A
PAAVONEN, J
LEHTOVIRTA, P
HYOTY, H
VESTERINEN, E
DILLNER, J
机构
[1] UNIV HELSINKI, CENT HOSP, DEPT OBSTET, SF-00100 HELSINKI 10, FINLAND
[2] KAROLINSKA INST, DEPT VIROL, S-10401 STOCKHOLM 60, SWEDEN
[3] UNIV HELSINKI, CENT HOSP, DEPT GYNECOL, SF-00100 HELSINKI 10, FINLAND
关键词
D O I
10.1136/jcp.45.6.494
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims To determine if there are type specific differences in serum antibody responses to synthetic peptides derive from human papillomavirus (HPV) open reading frame (ORF) E2 in patients wit cervical carcinoma. Methods Diagnostic phase sera from 8 age-matched women with cervical adenocarcinoma (AC), cervical squamous cell carcinoma (SC), ovarian cancer (OC) or no gynaecological malignancy were available. Serum IgG and IgA antibodies to synthetic peptides corresponding to a residue of HPV 6,11,16, and 18 ORF E2 18 amino acids long and a control peptide from mumps virus were determined by ELISA. Results Both IgA and IgG antibody positivity to the HPV 18 peptide were associated with increased risk (9.0-fold, confidence limits 1.5-199) for AC. IgA positivity to HPV 11, 16, and 18 peptides was associated with an increased risk for SC. However, the association of IgG antibodies to HPV 16 peptide with SC was not significant. IgA or IgG antibodies to HPV 6 or mumps virus peptides were not associated with increased risk for AC, SC, or OC. Conclusions These results suggest a specific role for HPV 18 in AC. Differences in antibody responses to HPV peptide in AC and SC suggest immunopathogenetic differences between the two types of cervical carcinoma.
引用
收藏
页码:494 / 497
页数:4
相关论文
共 21 条
[1]  
BIGGAR RJ, 1981, JNCI-J NATL CANCER I, V66, P439
[2]  
BRESLOW NE, 1990, IARC SCI PUBLICATION, V32
[3]   NUCLEOTIDE-SEQUENCE AND COMPARATIVE-ANALYSIS OF THE HUMAN PAPILLOMAVIRUS TYPE-18 GENOME - PHYLOGENY OF PAPILLOMAVIRUSES AND REPEATED STRUCTURE OF THE E6 AND E7 GENE-PRODUCTS [J].
COLE, ST ;
DANOS, O .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 193 (04) :599-608
[4]  
CONE R, 1989, J CELL BIOCHEM S, V13, P183
[5]  
CRUM CP, 1989, AM J PATHOL, V134, P1183
[6]   ANALYSIS OF THE PHYSICAL STATE OF DIFFERENT HUMAN PAPILLOMAVIRUS DNAS IN INTRAEPITHELIAL AND INVASIVE CERVICAL NEOPLASM [J].
CULLEN, AP ;
REID, R ;
CAMPION, M ;
LORINCZ, AT .
JOURNAL OF VIROLOGY, 1991, 65 (02) :606-612
[7]   THE NUCLEOTIDE-SEQUENCE AND GENOME ORGANIZATION OF HUMAN PAPILLOMA-VIRUS TYPE-11 [J].
DARMANN, K ;
SCHWARZ, E ;
GISSMANN, L ;
HAUSEN, HZ .
VIROLOGY, 1986, 151 (01) :124-130
[8]   A SYNTHETIC PEPTIDE DEFINES A SEROLOGIC IGA RESPONSE TO A HUMAN PAPILLOMAVIRUS-ENCODED NUCLEAR ANTIGEN EXPRESSED IN VIRUS-CARRYING CERVICAL NEOPLASIA [J].
DILLNER, J ;
DILLNER, L ;
ROBB, J ;
WILLEMS, J ;
JONES, I ;
LANCASTER, W ;
SMITH, R ;
LERNER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3838-3841
[9]   MAPPING OF LINEAR EPITOPES OF HUMAN PAPILLOMAVIRUS TYPE-16 - THE E1, E2, E4, E5, E6 AND E7 OPEN READING FRAMES [J].
DILLNER, J .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (04) :703-711
[10]  
HAUSEN HZ, 1989, CANCER RES, V49, P4677